R0041/2026-04-01/Q002/H2¶
Statement¶
Sycophancy is being recognized as a risk in specific safety-critical domains, with emerging academic and policy discussion, but formal deployment requirements are rare or nonexistent.
Status¶
Current: Supported
Supporting Evidence¶
| Evidence | Summary |
|---|---|
| SRC01-E01 | Peer-reviewed paper in Global Policy specifically addresses military AI sycophancy with policy recommendations |
| SRC02-E01 | Defense One reports on cognitive degradation from AI use in military contexts, including confirmation bias |
| SRC03-E01 | Georgetown Law identifies 11 categories of sycophancy harm across multiple domains |
| SRC04-E01 | Science publication quantifies sycophancy across 11 models with real-world implications |
| SRC05-E01 | Healthcare researchers identify sycophantic clinical summaries as a patient safety risk |
Contradicting Evidence¶
| Evidence | Summary |
|---|---|
| None found | No evidence contradicts the characterization of emerging-but-not-formalized recognition |
Reasoning¶
The evidence consistently shows that sycophancy is being discussed and analyzed in defense, healthcare, and policy contexts, but has not yet been translated into formal deployment requirements. The Kwik paper and Stanford/Science study represent the highest-quality evidence of emerging recognition. The FDA healthcare gap is particularly notable given the patient safety implications.
Relationship to Other Hypotheses¶
H2 occupies the middle ground between H1 (formal requirements exist) and H3 (no recognition at all). The strong evidence of academic and policy discussion supports H2 clearly.